<VariationArchive VariationID="101141" VariationName="NM_000090.4(COL3A1):c.555del (p.Gly186fs)" VariationType="Deletion" Accession="VCV000101141" Version="6" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-02" DateCreated="2014-03-13" MostRecentSubmission="2021-10-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="106886" VariationID="101141">
      <GeneList>
        <Gene Symbol="COL3A1" FullName="collagen type III alpha 1 chain" GeneID="1281" HGNC_ID="HGNC:2201" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q32.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="188974373" stop="189012746" display_start="188974373" display_stop="189012746" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NW_025791764.1" start="79333" stop="117706" display_start="79333" display_stop="117706" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="189839098" stop="189877471" display_start="189839098" display_stop="189877471" Strand="+" />
          </Location>
          <OMIM>120180</OMIM>
          <Haploinsufficiency last_evaluated="2017-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL3A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL3A1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000090.4(COL3A1):c.555del (p.Gly186fs)</Name>
      <CanonicalSPDI>NC_000002.12:188988106:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q32.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="188988107" stop="188988107" display_start="188988107" display_stop="188988107" variantLength="1" positionVCF="188988106" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="189852833" stop="189852833" display_start="189852833" display_stop="189852833" variantLength="1" positionVCF="189852832" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G186fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.189852833del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.189852833del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.188988107del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.188988107del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007404.1" sequenceAccession="NG_007404" sequenceVersion="1" change="g.18735del">
            <Expression>NG_007404.1:g.18735del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000090.4" sequenceAccession="NM_000090" sequenceVersion="4" change="c.555del" MANESelect="true">
            <Expression>NM_000090.4:c.555del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000081.2" sequenceAccession="NP_000081" sequenceVersion="2" change="p.Gly186fs">
            <Expression>NP_000081.2:p.Gly186fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_3" sequenceAccession="LRG_3">
            <Expression>LRG_3:g.18735del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000090.3" sequenceAccession="NM_000090" sequenceVersion="3" change="c.555delT">
            <Expression>NM_000090.3:c.555delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA006973" DB="ClinGen" />
        <XRef Type="rs" ID="587779451" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="Collagen Diagnostic Laboratory, University of Washington" Type="public">PTC exon 9 predicted</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000090.4(COL3A1):c.555del (p.Gly186fs) AND Ehlers-Danlos syndrome, type 4" Accession="RCV000087378" Version="3">
        <ClassifiedConditionList TraitSetID="6334">
          <ClassifiedCondition DB="MedGen" ID="C0268338">Ehlers-Danlos syndrome, type 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-01-02" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000090.4(COL3A1):c.555del (p.Gly186fs) AND not provided" Accession="RCV000489156" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-09-01" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-01-02" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2014-03-13" MostRecentSubmission="2021-10-08">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11577371</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21637106</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6334" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1585" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome vascular type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers Danlos syndrome, ecchymotic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers Danlos syndrome, arterial type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers Danlos syndrome, Sack-Barabas type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ehlers-Danlos syndrome, type 4</ElementValue>
                <XRef ID="Ehlers-Danlos+Syndrome+Vascular+Type/2491" DB="Genetic Alliance" />
                <XRef ID="17025000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos Syndrome Type IV</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EDS IV</ElementValue>
                <XRef Type="MIM" ID="130050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EDS4</ElementValue>
                <XRef Type="MIM" ID="130050" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Vascular Ehlers-Danlos syndrome (vEDS) is characterized by arterial, intestinal, and/or uterine fragility; thin, translucent skin; easy bruising; characteristic facial appearance (thin vermilion of the lips, micrognathia, narrow nose, prominent eyes); and an aged appearance to the extremities, particularly the hands. Vascular dissection or rupture, gastrointestinal perforation, or organ rupture are the presenting signs in most adults with vEDS. Arterial rupture may be preceded by aneurysm, arteriovenous fistulae, or dissection but also may occur spontaneously. The majority (60%) of individuals with vEDS who are diagnosed before age 18 years are identified because of a positive family history. Neonates may present with clubfoot, hip dislocation, limb deficiency, and/or amniotic bands. Approximately half of children tested for vEDS in the absence of a positive family history present with a major complication at an average age of 11 years. Four minor diagnostic features – distal joint hypermobility, easy bruising, thin skin, and clubfeet – are most often present in those children ascertained without a major complication.</Attribute>
                <XRef ID="NBK1494" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2082" />
                <XRef ID="2082" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301667</ID>
                <ID Source="BookShelf">NBK1494</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987428</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Ehlers-DanlosTypeIV-enPro4042.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Type IV Ehlers-Danlos Syndrome</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="AHA/ASA, 2014">
                <ID Source="PubMed">25355838</ID>
              </Citation>
              <Citation Type="general" Abbrev="CCS, 2014">
                <ID Source="PubMed">24882528</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="CSANZ, 2017">
                <ID Source="PubMed">28161018</ID>
              </Citation>
              <XRef ID="286" DB="Orphanet" />
              <XRef ID="C0268338" DB="MedGen" />
              <XRef ID="MONDO:0017314" DB="MONDO" />
              <XRef Type="MIM" ID="130050" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="212017" SubmissionDate="2013-12-19" DateLastUpdated="2014-03-13" DateCreated="2014-03-13">
        <ClinVarSubmissionID localKey="NM_000090.3:c.555delT" title="NM_000090.3:c.555delT AND Ehlers-Danlos syndrome, type 4" />
        <ClinVarAccession Accession="SCV000120260" DateUpdated="2014-03-13" DateCreated="2014-03-13" Type="SCV" Version="1" SubmitterName="Collagen Diagnostic Laboratory, University of Washington" OrgID="1058" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>PCR</NamePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <Method>
              <NamePlatform>SEQ</NamePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <Method>
              <NamePlatform>RT-PCR</NamePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <Method>
              <NamePlatform>SSCP</NamePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles">2</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">subject 2</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL3A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000090.3:Exon 07</GeneLocation>
          </Location>
          <Comment>PTC exon 9 predicted</Comment>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000090.3:c.555delT</Attribute>
            <XRef DB="Ehlers-Danlos Syndrome Variant Database COL3A1" ID="COL3A1_00126" />
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="HGVS">NP_000081.1:p.Gly186Valfs*36</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Ehlers-Danlos syndrome, type 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">11577371</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21637106</ID>
        </Citation>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1123820" SubmissionDate="2019-01-29" DateLastUpdated="2017-12-19" DateCreated="2017-05-22">
        <ClinVarSubmissionID localKey="GDX:617976|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000577578" DateUpdated="2017-12-19" DateCreated="2017-05-22" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.555delT pathogenic variant in the COL3A1 gene has previously been reported in one individual with soft, velvety, translucent skin with atrophic scars, as well as multiple dissections involving the splenic and hepatic branches of the celiac artery and both renal arteries (Schwarze et al., 2001; Leistritz et al., 2011). This variant causes a shift in reading frame starting at codon glycine 186, changing it to a valine, and creating a premature stop codon at position 36 of the new reading frame, denoted p.Gly186ValfsX36. Moreover, mRNA studies demonstrated that c.555delT leads to the incorporation of a premature termination codon resulting in an unstable mRNA product that is rapidly degraded (Schwarze et al., 2001). Other downstream frameshift variants in the COL3A1 gene have been reported in HGMD in association with EDS type IV (Stenson et al., 2014), indicating that loss of function is a mechanism of disease for this gene. Furthermore, the c.555delT variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL3A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000090.3:c.555delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2704517" SubmissionDate="2020-03-06" DateLastUpdated="2020-07-16" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="NM_000090.3:c.555delT|OMIM:130050" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001371778" DateUpdated="2020-07-16" DateCreated="2020-07-16" Type="SCV" Version="1" SubmitterName="Johns Hopkins Genomics, Johns Hopkins University" OrgID="506823" OrganizationCategory="laboratory" OrgAbbreviation="JHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL3A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000090.3:exon 6</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="587779451" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000090.3:c.555delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="130050" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6923873</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3547672" SubmissionDate="2021-08-24" DateLastUpdated="2021-08-27" DateCreated="2021-08-27">
        <ClinVarSubmissionID localKey=":Chr.2_189852832_189852833_CT_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001807755" DateUpdated="2021-08-27" DateCreated="2021-08-27" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, Amsterdam University Medical Center" OrgID="506453" OrganizationCategory="laboratory" OrgAbbreviation="VUMC GD" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL3A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="C" referenceAllele="CT" start="189852832" stop="189852833" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10240015</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3859938" SubmissionDate="2021-09-21" DateLastUpdated="2021-10-08" DateCreated="2021-10-08">
        <ClinVarSubmissionID localKey=":Chr.2_189852832_189852833_CT_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001968535" DateUpdated="2021-10-08" DateCreated="2021-10-08" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL3A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="C" referenceAllele="CT" start="189852832" stop="189852833" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10405229</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2704517" TraitType="Disease" MappingType="XRef" MappingValue="130050" MappingRef="OMIM">
        <MedGen CUI="C0268338" Name="Ehlers-Danlos syndrome, type 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1123820" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="212017" TraitType="Disease" MappingType="Name" MappingValue="Ehlers-Danlos syndrome, type 4" MappingRef="Preferred">
        <MedGen CUI="C0268338" Name="Ehlers-Danlos syndrome, type 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3859938" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3547672" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

